# M13 Batch 53 — Lane 02 content-based risk screen

Date: 2026-11-12  
Queue source revision: `33ef97e7ba6a9e91aebaee198cfead532faa4185`  
Scope: 20 exact Claim statements in lane 02. Routing screen only; not source-fit adjudication, D/E/B scoring, specialist approval, Human View, or release clearance.

## Risk routing

| Claim IDs | Route | Rationale |
|---|---|---|
| `CLM-MOLECULAR_BIOLOGY_BASICS-A/B/C` | ELEVATED — biological sciences | Claims describe genetic information and molecular processes. The current statements are foundational rather than laboratory instructions, but they can underpin downstream biotechnology or health claims. Require molecular-biology review; do not infer protocol, clinical or genetic-engineering guidance. |
| `CLM-NEUROSCIENCE_BASICS-A/B/C` | ELEVATED — neuroscience/health | The statements touch nervous-system function and research into neurological disease and treatment. Require neuroscience/clinical specialist review before extending them into diagnosis, treatment or behavioural advice. |
| `CLM-MODELING_BASICS-C` | MODERATE — model interpretation | Important epistemic safeguard: model outputs are conditional on assumptions and scope. Check that examples preserve this limitation. |
| `CLM-MONEY_AND_BANKING_BASICS-B` | MODERATE — financial/economic concepts | Monetary aggregate classifications vary by jurisdiction, central-bank definition and period. Require a dated, jurisdiction-specific source before operational or policy use. |
| `CLM-OPERATIONS_RESEARCH_BASICS-A/B/C` | MODERATE — decision support | Operations-research methods can inform consequential allocation and planning decisions. Require assumptions, data quality and decision-context review. |
| `CLM-OPTIMIZATION_BASICS-A/B` | MODERATE — mathematical decision methods | Objective functions, constraints and method families are foundational, but application can affect resource allocation. Keep conclusions bounded by the model and problem formulation. |
| `CLM-MUSIC_THEORY_BASICS-A/B/C` | LOW direct consequence — arts education | Foundational terminology and notation claims. Review source fit and terminology consistency. |
| `CLM-NEGOTIATION_BASICS-A/B` | LOW direct consequence — social/communication concepts | General descriptive claims. Do not turn them into universal behavioural prescriptions without context-specific evidence. |
| `CLM-OPEN_SCIENCE_BASICS-B/C` | LOW direct consequence — research infrastructure | Descriptive scope and epistemic distinction. Openness is not evidence of truth; preserve that limitation. |

## Disposition

- Claim statements screened: 20/20.
- Elevated routing: 6 (3 molecular biology, 3 neuroscience).
- Moderate routing: 7 (modeling 1, money/banking 1, operations research 3, optimization 2).
- Low direct-consequence routing: 7 (music theory 3, negotiation 2, open science 2).
- D/E/B scores assigned: 0.
- Claims accepted or release-cleared: 0.
- Canonical Claim/Evidence Use/Source JSON changed: 0.
- Specialist review completed: 0.
- Lane status: RISK SCREEN COMPLETE FOR ROUTING; SOURCE-PASSAGE REVIEW AND SCORING HOLD.

## Required next work

1. Inspect each Claim → Evidence Use → Source chain and retrieve exact source passages.
2. Prioritize molecular biology and neuroscience for domain-specific review.
3. Keep monetary aggregate claims jurisdiction- and date-scoped.
4. Keep operations-research and optimization claims conditional on assumptions, data and decision context.
5. Keep all Claims HOLD until exact source passages and D/E/B assessment are recorded.
